Ramelteon
Ramelteon > Ramelteon is a selective melatonin receptor agonist (MT₁/MT₂) approved for the short‑term treatment of insomnia characterized by difficulty falling asleep. It offers a non‑benzodiazepine pharmacologic profile with minimal…
Raloxifene
Raloxifene Mechanism of Action Raloxifene is a selective estrogen receptor modulator (SERM). Bone: Acts as an estrogen agonist at osteoblastic ERβ receptors → ↑ bone formation, ↓ resorption. Breast: Exerts…
Rabeprazole
Rabeprazole Rabeprazole is a potent proton‑pump inhibitor (PPI) used to decrease gastric acid secretion in various acid‑related disorders. Mechanism of Action Rabeprazole irreversibly inhibits the H⁺/K⁺‑ATPase enzyme (the proton pump)…
Qvar Redihaler
Qvar Redihaler Qvar Redihaler (fluticasone propionate) is a dry‑powder inhaled corticosteroid (ICS) used for maintenance treatment of persistent asthma in adults and children ≥6 years. Mechanism of Action Glucocorticoid receptor binding:…
Qvar
Qvar Qvar® (mometasone furoate) is a high‑potency, low‑potency intranasal corticosteroid indicated for the long‑term control of allergic rhinitis. --- Mechanism of Action Receptor binding: Mometasone furoate is a synthetic glucocorticoid…
Quzyttir
Quzyttir Quzyttir is an investigational quinolone‑class antibacterial developed as a next‑generation agent targeting both Gram‑positive and Gram‑negative bacteria with improved safety and efficacy profiles. Mechanism of Action Quzyttir inhibits bacterial…
Quviviq
Quviviq Quviviq (oxybutynin) is a delayed‑release antimuscarinic agent approved for the long‑term management of idiopathic overactive bladder (OAB) in adults. Mechanism of Action Direct antagonist of muscarinic acetylcholine receptors (primarily…
Qutenza
Qutenza Qutenza (capsaicin 8 % dermal patch) is a high‑potency, topical analgesic indicated for the treatment of neuropathic pain from post‑herpetic neuralgia and peripheral neuropathy in adults with a suitable total…
Qulipta
Qulipta Mechanism of Action Qulipta (ubrogepant) is a calcitonin gene‑related peptide (CGRP) receptor antagonist. It selectively blocks the CGRP receptor on trigeminal neurons and vascular smooth muscle, preventing CGRP‑mediated vasodilation…
Quizartinib
Quizartinib Quizartinib (trade name Qurax in some regions) is a highly selective oral FLT3 tyrosine‑kinase inhibitor indicated for the treatment of FLT3‑internal tandem duplication (ITD)‑positive acute myeloid leukemia (AML) that…